Terlipressin vs other vasoactive drugs
Non‐serious adverse events: diarrhoea or abdominal pain, or both · people with cirrhosis and hepatorenal syndrome
It is very uncertain whether terlipressin changes non‐serious adverse events: diarrhoea or abdominal pain, or both compared with other vasoactive drugs (very low certainty).
1 finding from 1 review
- Terlipressin versus other vasoactive drugs for hepatorenal syndrome 2017 · Cochrane Headline outcomes onlyRR 3.5 [1.19, 10.27]221 participantsVery low